NanoViricides Inc. (NNVC)

[bloomvest]

If the problem were no toxicity this would have been completed years ago. I still cant believe any adult would fall for that BS put out by Diwan and Seymour.

The FDA and CDC would be banging down their doors and offering millions of $$$$.

Sometimes one has to step back and think logically.

Right now I stepped back from trading NNVC as I believe the index funds have already bought in. I'll wait for the coming decline and then reenter.

Others can probably answer this better, but my understanding is the previous studies were designed to show efficacy of the drug at various dosage levels, not to test the limits of toxicity of the drug at higher dosage levels. They need, as part of the FDA approval process, to discover the dosage (relative to body weight, probably) at which the drug itself becomes harmful. Only when that's known can human Clinial Trial drug protocols be designed and administered to test efficacy in humans. This is the purpose of Toxicology studies.

Some drugs, like cancer drugs, have a very narrow range between efficacy and toxicity -- the level at which therapeutic effects are demonstrated is not far from the level at which the drug itself becomes dangerous. But as I said, the problem NanoViricides has is that their drugs have demonstrated zero toxicity in all previous pre-clinical trials at all dosage levels where therapeutic efficacy has been shown, so that point at which a large dosage becomes dangerous might be such a very high amount as to be difficult to test for and discover. Again, a good problem to have long term, but something that is causing us delays here in the toxicology stage of the approval process.

Best to all.